Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1472581rdf:typepubmed:Citationlld:pubmed
pubmed-article:1472581lifeskim:mentionsumls-concept:C0162371lld:lifeskim
pubmed-article:1472581lifeskim:mentionsumls-concept:C0024264lld:lifeskim
pubmed-article:1472581lifeskim:mentionsumls-concept:C0034819lld:lifeskim
pubmed-article:1472581lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:1472581lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:1472581lifeskim:mentionsumls-concept:C1522405lld:lifeskim
pubmed-article:1472581lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:1472581lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:1472581lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:1472581lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:1472581lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:1472581lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:1472581pubmed:issue6lld:pubmed
pubmed-article:1472581pubmed:dateCreated1993-2-1lld:pubmed
pubmed-article:1472581pubmed:abstractTextWe report the phenotypical and functional characterization of a cord blood mononuclear lymphocyte subset (CBMC) which expresses the p55 chain of interleukin-2 receptor (IL-2R, CD25). The great majority of CD25-positive CBMC are activated CD3-positive T lymphocytes in that most of them are HLA-DR-positive, coexpress both CD4 and CD8 antigens and at least a part of them display high affinity IL-2R. In keeping with the expression of both chains of IL-2R (p55 and p75), enriched CD25-positive CBMC are able to display strong IL-2-induced proliferation and lymphokine-activated killing activity. The percentage of CD25-positive cells is higher in cord blood than in adult peripheral blood and their presence could be peculiarly important in the neonatal period, when specific T-cell-mediated immune responses are still on their way to full maturation.lld:pubmed
pubmed-article:1472581pubmed:languageenglld:pubmed
pubmed-article:1472581pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1472581pubmed:citationSubsetIMlld:pubmed
pubmed-article:1472581pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1472581pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1472581pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1472581pubmed:statusMEDLINElld:pubmed
pubmed-article:1472581pubmed:issn0006-3126lld:pubmed
pubmed-article:1472581pubmed:authorpubmed-author:MarconiMMlld:pubmed
pubmed-article:1472581pubmed:authorpubmed-author:MaccarioRRlld:pubmed
pubmed-article:1472581pubmed:authorpubmed-author:MorettaAAlld:pubmed
pubmed-article:1472581pubmed:authorpubmed-author:MingratGGlld:pubmed
pubmed-article:1472581pubmed:authorpubmed-author:GasparoniAAlld:pubmed
pubmed-article:1472581pubmed:authorpubmed-author:MontagnaDDlld:pubmed
pubmed-article:1472581pubmed:authorpubmed-author:GiaroliEElld:pubmed
pubmed-article:1472581pubmed:issnTypePrintlld:pubmed
pubmed-article:1472581pubmed:volume62lld:pubmed
pubmed-article:1472581pubmed:ownerNLMlld:pubmed
pubmed-article:1472581pubmed:authorsCompleteYlld:pubmed
pubmed-article:1472581pubmed:pagination385-94lld:pubmed
pubmed-article:1472581pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1472581pubmed:meshHeadingpubmed-meshheading:1472581-...lld:pubmed
pubmed-article:1472581pubmed:meshHeadingpubmed-meshheading:1472581-...lld:pubmed
pubmed-article:1472581pubmed:meshHeadingpubmed-meshheading:1472581-...lld:pubmed
pubmed-article:1472581pubmed:meshHeadingpubmed-meshheading:1472581-...lld:pubmed
pubmed-article:1472581pubmed:meshHeadingpubmed-meshheading:1472581-...lld:pubmed
pubmed-article:1472581pubmed:meshHeadingpubmed-meshheading:1472581-...lld:pubmed
pubmed-article:1472581pubmed:meshHeadingpubmed-meshheading:1472581-...lld:pubmed
pubmed-article:1472581pubmed:meshHeadingpubmed-meshheading:1472581-...lld:pubmed
pubmed-article:1472581pubmed:meshHeadingpubmed-meshheading:1472581-...lld:pubmed
pubmed-article:1472581pubmed:meshHeadingpubmed-meshheading:1472581-...lld:pubmed
pubmed-article:1472581pubmed:meshHeadingpubmed-meshheading:1472581-...lld:pubmed
pubmed-article:1472581pubmed:year1992lld:pubmed
pubmed-article:1472581pubmed:articleTitleIn vivo activated cord blood lymphocytes express high affinity interleukin-2 receptor: evaluation of their responsiveness to in vitro stimulation with recombinant interleukin-2.lld:pubmed
pubmed-article:1472581pubmed:affiliationDepartment of Pediatrics, University of Pavia, Italy.lld:pubmed
pubmed-article:1472581pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1472581lld:pubmed